List view / Grid view
11 March 2015 | By The European Investment Bank
The European Investment Bank has agreed to provide GBP 109 million for the construction of a new District and General Hospital in Dumfries that will ensure modern health-care for people living in the south-west of Scotland...
11 March 2015 | By Novo Nordisk
Latest data announced at Diabetes UK reinforces the long-term efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes...
11 March 2015 | By GlobalData
The steady decline in new Ebola cases presents a formidable challenge to current and future clinical trials of investigational treatments for the disease, as it will be more difficult to recruit study participants and demonstrate efficacy, says an analyst with research and consulting firm GlobalData...
11 March 2015 | By Roche
New option for patients as NICE accepts Gazyvaro® (obinutuzumab) for treatment of most common adult leukaemia...
10 March 2015 | By GBI Research
Patent applications for novel pain therapeutics declined steadily in number from 4,970 in 2008 to 3,492 in 2012, an average annual decrease of 8%, as limited understanding of pain pathophysiology continues to hinder drug development in this arena, says business intelligence provider GBI Research...
9 March 2015 | By Novo Nordisk
New data from the phase 3a SCALE™ Obesity and Prediabetes trial were presented at The Endocrine Society’s 97th Annual Meeting (ENDO), showing that adults with obesity or who are overweight with comorbidities who had lost ≥5% of their body weight at 56 weeks (ie weight loss responders), demonstrated greater improvements…
9 March 2015 | By Gilead Sciences
New oral treatment for Chronic Lymphocytic Leukaemia now approved for use within NHS Scotland...
6 March 2015 | By GlobalData
“AbbVie’s acquisition of Pharmacyclics (PCYC), valued at $21 billion, will help the company alleviate its dependency on Humira, which accounted for 62% of its total revenues in 2014, up from 57% in 2013..."
6 March 2015 | By AOP Orphan
AOP Orphan Pharmaceuticals AG reported the completion of recruitment for its phase III trial PROUD-PV to support global licensure of Ropeginterferon alfa 2b (AOP2014/P1101), a novel, long-acting, mono-pegylated Interferon for the treatment of Polycythemia Vera...
5 March 2015 | By NHS Confederation
Personal health budgets are “complex” to introduce but the financial challenges of implementing them can be minimised if providers and commissioners work together, according to a briefing paper published ahead of their expansion from next month...
5 March 2015 | By Rottendorf Pharmaceuticals
Positioned as top 20 contract development and manufacturing organization recognized by five 2015 CMO leadership awards...
5 March 2015 | By Chamaeleo Pharma
Chamaeleo Pharma NV, a Belgium-based oncology company, announced that Han Van ‘t Klooster has joined Chamaeleo as Vice President of Commercial Operations...
5 March 2015 | By Bristol-Myers Squibb
Bristol-Myers Squibb Company announced an approval of an additional indication for Opdivo (nivolumab) by the U.S. Food and Drug Administration...
5 March 2015 | By H. Lundbeck A/S
Lundbeck today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for a Type-II Variation related to the update of the European summary of the product characteristics (SmPC) for Brintellix...
4 March 2015 | By Reed Sinopharm Exhibitions
The Health Industry Summit, EXPO and Congress (tHIS) held in May in Shanghai announced further increases in size to reach 280,000sqm ahead of its grand opening...
